{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:29:36Z","timestamp":1771903776979,"version":"3.50.1"},"reference-count":53,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To perform a COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN)-based systematic literature review of measurement properties of the Polymyalgia Rheumatica Activity Score (PMR-AS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>PubMed, EMBASE, and CINAHL were broadly searched. English full-text articles, with (quantitative) data on \u2265 5 patients with PMR using the PMR-AS were selected. Seven hypotheses for construct validity and 3 for responsiveness, concerning associations with erythrocyte sedimentation rate, physical function, quality of life, clinical disease states, ultrasound, and treatment response, were formulated. We assessed the structural validity, internal consistency, reliability, and measurement error, or the hypotheses on construct validity or responsiveness of the PMR-AS based on COSMIN criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Out of the identified 26 articles that used the PMR-AS, we were able to use 12 articles. Structural validity, internal consistency, construct validity, and responsiveness were assessed in 1, 2, 8, and 3 articles, respectively. Insufficient evidence was found to confirm structural validity and internal consistency. No data were found on reliability or measurement error. Although 60% and 67% of hypotheses tested for construct validity and responsiveness, respectively, were confirmed, there was insufficient evidence to meet criteria for good measurement properties.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>While there is some promising evidence for construct validity and responsiveness of the PMR-AS, it is lacking for other properties and, overall, falls short of criteria for good measurement properties. Therefore, further research is needed to assess its role in clinical research and care.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.211292","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T13:20:27Z","timestamp":1646140827000},"page":"627-634","source":"Crossref","is-referenced-by-count":7,"title":["Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review"],"prefix":"10.3899","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-3515","authenticated-orcid":false,"given":"Thomas E.","family":"Bolhuis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizanne E.A.","family":"Nizet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2694-5411","authenticated-orcid":false,"given":"Claire","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-4079","authenticated-orcid":false,"given":"Alfons A.","family":"den Broeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4352-2824","authenticated-orcid":false,"given":"Cornelia H.M.","family":"van den Ende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aatke","family":"van der Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"2022062202351342000_49.6.627.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31825-1"},{"key":"2022062202351342000_49.6.627.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207492"},{"key":"2022062202351342000_49.6.627.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207524"},{"key":"2022062202351342000_49.6.627.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211734"},{"key":"2022062202351342000_49.6.627.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.011379"},{"key":"2022062202351342000_49.6.627.6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150515"},{"key":"2022062202351342000_49.6.627.7","doi-asserted-by":"crossref","unstructured":"Mokkink LB , Prinsen CAC , Patrick DL , COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs). [Internet. Accessed March 3, 2022.] Available from: https:\/\/www.cosmin.nl\/wp-content\/uploads\/COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018-1.pdf","DOI":"10.1007\/978-3-319-69909-7_2972-2"},{"key":"2022062202351342000_49.6.627.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"2022062202351342000_49.6.627.9","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"2022062202351342000_49.6.627.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.38.5.434"},{"key":"2022062202351342000_49.6.627.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.40.1.1"},{"key":"2022062202351342000_49.6.627.12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-5-672"},{"key":"2022062202351342000_49.6.627.13","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(84)90012-X"},{"key":"2022062202351342000_49.6.627.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200329"},{"key":"2022062202351342000_49.6.627.15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133850"},{"key":"2022062202351342000_49.6.627.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.02.006"},{"key":"2022062202351342000_49.6.627.17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2002.002618"},{"key":"2022062202351342000_49.6.627.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.22771"},{"key":"2022062202351342000_49.6.627.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.23095"},{"key":"2022062202351342000_49.6.627.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.23338"},{"key":"2022062202351342000_49.6.627.21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep286"},{"key":"2022062202351342000_49.6.627.22","doi-asserted-by":"publisher","DOI":"10.1186\/ar3140"},{"key":"2022062202351342000_49.6.627.23","doi-asserted-by":"crossref","first-page":"R186","DOI":"10.1186\/ar4017","article-title":"Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-\u03b1 blocking etanercept treatment","volume":"14","author":"Kreiner","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2022062202351342000_49.6.627.24","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110866"},{"key":"2022062202351342000_49.6.627.25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131055"},{"key":"2022062202351342000_49.6.627.26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes294"},{"key":"2022062202351342000_49.6.627.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3287-z"},{"key":"2022062202351342000_49.6.627.28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s10067-014-2650-y","article-title":"Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy","volume":"35","author":"Mori","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2022062202351342000_49.6.627.29","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208742"},{"key":"2022062202351342000_49.6.627.30","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/rheumatology\/kex477","article-title":"Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable","volume":"57","author":"Devauchelle-Pensec","year":"2018","journal-title":"Rheumatology"},{"key":"2022062202351342000_49.6.627.31","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.39740","article-title":"Brief report: a prospective open-label phase IIa trial of tocilizumab in the treatment of polymyalgia rheumatica","volume":"68","author":"Lally","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2022062202351342000_49.6.627.32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5114\/reum.2017.71642","article-title":"Relapse of polymyalgia rheumatica after a fall","volume":"55","author":"Manzo","year":"2017","journal-title":"Reumatologia"},{"key":"2022062202351342000_49.6.627.33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/rheumatology\/kex169","article-title":"Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica","volume":"56","author":"Carvajal Alegria","year":"2017","journal-title":"Rheumatology"},{"key":"2022062202351342000_49.6.627.34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13075-017-1499-2","article-title":"Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab","volume":"20","author":"Huwart","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2022062202351342000_49.6.627.35","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/1756-185X.13723","article-title":"Tocilizumab monotherapy for polymyalgia rheumatica: a prospective, single-center, open-label study","volume":"22","author":"Chino","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2022062202351342000_49.6.627.36","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1093\/rheumatology\/keaa054","article-title":"Association of mucosal-associated invariant T cells with different disease phases of polymyalgia rheumatica","volume":"59","author":"Nakajima","year":"2020","journal-title":"Rheumatology"},{"key":"2022062202351342000_49.6.627.37","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00259-020-04731-z","article-title":"Abnormalities at three musculoskeletal sites on whole-body positron emission tomography\/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity","volume":"47","author":"Owen","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2022062202351342000_49.6.627.38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40744-021-00299-8","article-title":"Inflammatory markers are quickly improved by tocilizumab in early polymyalgia rheumatica and might predict early response to interleukin-6 blockade","volume":"8","author":"Carvajal Alegria","year":"2021","journal-title":"Rheumatol Ther"},{"key":"2022062202351342000_49.6.627.39","doi-asserted-by":"crossref","first-page":"105117","DOI":"10.1016\/j.jbspin.2020.105117","article-title":"Tocilizumab controls bone turnover in early polymyalgia rheumatica","volume":"88","author":"Carvajal Alegria","year":"2021","journal-title":"Joint Bone Spine"},{"key":"2022062202351342000_49.6.627.40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/1756-185X.14000","article-title":"Neutrophil to lymphocyte ratio predicts glucocorticoid resistance in polymyalgia rheumatica","volume":"24","author":"Owen","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2022062202351342000_49.6.627.41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/HACCE.S5012","article-title":"Muscle functions in polymyalgia rheumatica and giant-cell arteritis","volume":"2","author":"Bj\u00f6rkman","year":"2010","journal-title":"Healthy Aging Clin Care Elder"},{"key":"2022062202351342000_49.6.627.42","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S38443"},{"key":"2022062202351342000_49.6.627.43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jclinepi.2018.07.007","article-title":"Handling the reflective-formative measurement conundrum: a practical illustration based on sustainable employability","volume":"103","author":"Fleuren","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"2022062202351342000_49.6.627.44","doi-asserted-by":"publisher","DOI":"10.1207\/S15327752JPA8003_01"},{"key":"2022062202351342000_49.6.627.45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520250075037"},{"key":"2022062202351342000_49.6.627.46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1874312901307010058","article-title":"The relationship between function and disease activity as measured by the HAQ and DAS28 varies over time and by rheumatoid factor status in early inflammatory arthritis (EIA). Results from the CATCH Cohort","volume":"7","author":"Boyd","year":"2013","journal-title":"Open Rheumatol J"},{"key":"2022062202351342000_49.6.627.47","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101075"},{"key":"2022062202351342000_49.6.627.48","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000100"},{"key":"2022062202351342000_49.6.627.49","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113555"},{"key":"2022062202351342000_49.6.627.50","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160090"},{"key":"2022062202351342000_49.6.627.51","doi-asserted-by":"publisher","DOI":"10.1002\/art.22630"},{"key":"2022062202351342000_49.6.627.52","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200248"},{"key":"2022062202351342000_49.6.627.53","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088526"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.211292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T07:34:45Z","timestamp":1700292885000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.211292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.3899\/jrheum.211292"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.211292","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}